Chloé Voyer
🎓 MSc Mental Health, McGill University

Chloé is a master’s student in Mental Health at McGill University, co-supervised by Dr. Ian Gold and Dr. Geneviève Sauvé. A recipient of 3 excellence scholarships during her first year, she holds a bachelor’s degree in psychology from the same university and aspires to pursue doctoral studies in clinical psychology.
Her research is part of the Minds@Work-ADHD study, a randomized controlled trial examining quality of work life among adults with ADHD. What particularly motivates her in her field is the opportunity to transform research knowledge into concrete interventions to improve the quality of work life for adults with ADHD.
In her free time, Chloé is an amateur athlete who enjoys running and cycling.
She also has a nifty greenthumb, a passion for houseplants that grew out of the confinement period during the COVID-19 pandemic and has stayed with her since.
news
Feb 26, 2025 | Featured in the Douglas Research Centre Trainee spotlight ⭐ |
---|---|
Jan 23, 2025 | I will be presenting preliminary findings from the Minds@Work-ADHD study at the 10th World Congress on ADHD in Prague! ✈️ |
Dec 03, 2024 | Our lab will be presenting “Innovative practices promoting workplace inclusion for people with ADHD and/or borderline personality disorder (BPD)” at QUARIERA-2025 📣 |
Nov 08, 2024 | New publication: Strengths and challenges to embrace ADHD in employment–A systematic review ⭐ |
Oct 18, 2024 | Won Best Presentation Award at the CoP-SMT conference! 🏆 |
latest posts
Feb 26, 2025 | Douglas Research Centre | Trainee Spotlight – Chloé Voyer 🌟 |
---|---|
Dec 03, 2024 | Upcoming Presentation: QUARIERA 2025 🎙️ |
Nov 27, 2024 | ADHD in the Workplace: Understanding Challenges & Embracing Strengths 🧠 |
Nov 01, 2024 | Protecting Academia: How to Identify and Avoid Predatory Publishing Practices 🦉 |
Oct 15, 2024 | Psychology Conferences 🎙️ |
selected publications
- ADHD@WorkStrengths and challenges to embrace attention-deficit/hyperactivity disorder in employment—A systematic reviewNeurodiversity
Nov 8, 2024